Edition:
United States

Stemline Therapeutics Inc (STML.OQ)

STML.OQ on NASDAQ Stock Exchange Capital Market

11.37USD
15 Nov 2018
Change (% chg)

-- (--)
Prev Close
$11.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,840
52-wk High
$20.55
52-wk Low
$11.08

Chart for

About

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics. The Company is developing approximately three clinical stage product candidates, including SL-401, SL-701 and SL-801. SL-401 is a targeted therapy directed to the... (more)

Overall

Beta: 0.71
Market Cap(Mil.): $372.39
Shares Outstanding(Mil.): 31.80
Dividend: --
Yield (%): --

Financials

  STML.OQ Industry Sector
P/E (TTM): -- 79.62 29.34
EPS (TTM): -3.00 -- --
ROI: -123.30 -0.41 13.58
ROE: -123.50 -3.13 15.11

Earnings vs. Estimates